A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

NCT05706506 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: Tirzepatide

Sponsor

Eli Lilly and Company